Peter Rossing
Overview
Explore the profile of Peter Rossing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
614
Citations
20140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hansen A, Christiansen C, Brons C, Engelhard L, Hansen T, Nielsen J, et al.
Diabetologia
. 2025 Feb;
PMID: 39891704
Aims/hypothesis: Low birthweight (LBW) is associated with younger age, less obesity and more hypertension among people recently diagnosed with type 2 diabetes, as well as increased cardiovascular morbidity and mortality...
12.
Akerkar A, Ronn P, Kosjerina V, Hansen C, Hulman A, Persson F, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):2284-2287.
PMID: 39838911
No abstract available.
13.
Legido-Quigley C, Wewer Albrechtsen N, Baek Blond M, Corrales Compagnucci M, Ernst M, Herrgard M, et al.
Nat Med
. 2025 Jan;
31(2):360-361.
PMID: 39825150
No abstract available.
14.
Mentz R, Anker S, Pitt B, Rossing P, Ruilope L, Gebel M, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39823276
Aims: This post hoc analysis aimed to assess the efficacy and safety of the non-steroidal mineralocorticoid receptor antagonist finerenone by baseline diuretic use in FIDELITY, a pre-specified pooled analysis of...
15.
Huang Y, Stinson S, Thodberg M, Holm L, Thielemann R, Sulek K, et al.
EBioMedicine
. 2025 Jan;
112:105537.
PMID: 39753034
Background: Lipid species are emerging as biomarkers for cardiometabolic risk in both adults and children. The genetic regulation of lipid species and their impact on cardiometabolic risk during early life...
16.
Hauge S, Hjortkjaer H, Persson F, Theilade S, Frost M, Jorgensen N, et al.
J Diabetes Complications
. 2024 Dec;
39(2):108927.
PMID: 39708433
Aim: To explore the association between bone disorder and the risk for progression of diabetic kidney disease (DKD) in persons with type 1 diabetes mellitus (T1DM). Methods: In this prospective...
17.
Poulsen C, Jesse K, Carstensen B, Frimodt-Moller M, Hansen T, Persson F, et al.
Kidney Int Rep
. 2024 Dec;
9(12):3403-3413.
PMID: 39698347
Introduction: Individuals with type 1 diabetes (T1D) and diabetic nephropathy (DN) experience progressive kidney function decline and high risk of cardiovascular disease (CVD) and mortality. This study explored changes in...
18.
Heinrich N, Pedersen R, Vestergaard M, Lindberg U, Andersen U, Haddock B, et al.
J Diabetes Complications
. 2024 Dec;
39(2):108923.
PMID: 39647261
Background And Hypothesis: The kidneys may be susceptible to ectopic fat and its lipotoxic effects, disposing them to chronic kidney disease (CKD) in type 2 diabetes (T2D). We investigated whether...
19.
Andersen J, Rasmussen A, Engberg S, Bencke J, Frimodt-Moller M, Kirketerp-Moller K, et al.
BMJ Open Diabetes Res Care
. 2024 Dec;
12(6.
PMID: 39631844
Introduction: The aim of this study was to evaluate the effects of flexor tendon tenotomy treatment of the diabetic hammertoe deformity on plantar pressure. Research Design And Methods: The study...
20.
Badve S, Bilal A, Lee M, Sattar N, Gerstein H, Ruff C, et al.
Lancet Diabetes Endocrinol
. 2024 Nov;
13(1):15-28.
PMID: 39608381
Background: GLP-1 receptor agonists reduce the risk of major adverse cardiovascular events (MACE) and can also have kidney benefits. However, whether GLP-1 receptor agonists improve clinically important kidney outcomes remains...